Zoetis reported $2.4B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
AbbVie USD 17.4B 410M Sep/2026
Align Technology USD 1.02B 40M Sep/2026
Bayer EUR 10.05B 820M Sep/2026
Bristol-Myers Squibb USD 13.07B 100M Sep/2026
Charles River Laboratories USD 982.7M 17.3M Sep/2026
Coherus Biosciences USD 12.75M 1.18M Dec/2025
Dentsply International USD 836M 62M Sep/2026
Eli Lilly USD 24.4B 1.43B Sep/2026
Henry Schein USD 3.47B 10M Sep/2026
Idexx Laboratories USD 1.21B 10M Sep/2026
Illumina USD 1.17B 10M Sep/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
J&J USD 25.4B 89M Sep/2026
Laboratory Of America USD 3.81B 80M Sep/2026
Merck USD 18.1B 1.5B Sep/2026
Neogen USD 222.8M 2.5M Jun/2026
Pacira USD 176.65M 15.75M Sep/2026
Perrigo USD 989M 31M Sep/2026
Pfizer USD 16.6B 1.57B Sep/2026
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Quest Diagnostics USD 3.1B 57M Sep/2026
Sanofi EUR 14.44B 2.49B Sep/2026
Sanofi EUR 12.3B 160M Jun/2026
Zoetis USD 2.4B 100M Sep/2026